• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    With Fermion, start the journey of your innovative API.
    All News #Library

    FDA to Revise ADHD Drug Labels Over Weight Loss Risk in Kids

    REUTERS

    US Says It Halts Healthcare Fraud Schemes Worth Nearly $15 B

    REUTERS

    Amgen, Zai Say Stomach Cancer Candidate Hits Phase 3 Mark

    BIOSPACE

    Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

    PR NEWSWIRE

    AbbVie to buy Capstan for up to $2.1B in Immunology Push

    PRESS RELEASE

    EUROAPI sells Haverhill site to Particle Dynamics

    PRESS RELEASE

    Hikma Pharmaceuticals Usa Invests $1 Billion in US Expansion

    FIERCE PHARMA

    INmune Bio`s Alzheimer`s Drug Falls Short of Mid-Stage Study Goal

    REUTERS

    Pliant Ends Lung Disease Program Over Rise in Adverse Events

    FIERCE BIOTECH

    Medac Unveils New Methotrexate Data For Arthritis At EULAR 2025

    PRESS RELEASE

    Riliprubart Wins Japan Orphan Drug Tag for CIDP Therapy

    PRESS RELEASE

    Changes to the Roche Enlarged Corporate Executive Committee

    GLOBENEWSWIRE

    argenx progresses ARGX-119 for Congenital Myasthenic Syndromes

    GLOBENEWSWIRE

    Addex Leads CHF 2M Investment in Stalicla for Precision Medicine

    GLOBENEWSWIRE

    Idorsia`s lab-made glycan vaccine platform validated in humans

    GLOBENEWSWIRE

    Press release: Availability of the Q2 2025 Aide mémoire

    PRESS RELEASE

    Nicox: Last Patient Completes NCX 470 Denali Phase 3 Trial

    GLOBENEWSWIRE

    AB Science updates loan repayment terms with creditors

    GLOBENEWSWIRE

    Syngenta to Lead in Biologicals, Expanding Solutions for Farmers

    BUSINESSWIRE

    Innovent Biologics Unveils "Dual Innovations" at Oncology R&D Day

    PR NEWSWIRE

    Turnstone, once allied with AbbVie, accepts $8M Xoma buyout

    FIERCE BIOTECH

    NATO Fund Backs Biotech in Push to Counter Biological Threats

    REUTERS

    Moderna Flu Shot More Effective Than Approved Vaccine In Study

    REUTERS

    Torrent Pharma To Acquire JB Chemicals Stake From KKR

    BUSINESSWIRE

    Smith+nephew Sponsors Wimbledon Players, Showcasing Joint Repair

    GLOBENEWSWIRE

    Aurinia to Share AUR200 Ph1 Study Results on June 30, 2025

    BUSINESSWIRE

    Zambon Launches Intravenous Formulation of Fluimucil

    INDPHARMAPOST

    Sartorius Expands Manufacturing and R&D for Bioprocess in France

    INDPHARMAPOST

    Alembic Announces USFDA Final Approval for Single-Dose Vials

    INDPHARMAPOST

    Neuland Labs Gets EIR from USFDA for Pashamylaram Unit 2

    INDPHARMAPOST

    EMA Starts Review of Sodium Oxybate in Alcohol Dependence

    INDPHARMAPOST

    Shukra Pharmaceuticals receives LoA from RMSCL

    INDPHARMAPOST

    ESOT Congress 2025: scientists Create Human Islets in 3D Printing

    PR NEWSWIRE

    Glaukos Nets EU Green Lights for Glaucoma Surgery Micro-Stents

    FIERCE BIOTECH

    Gilead Blames Low Infection Rates for Ending 2 RSV Trials

    FIERCE BIOTECH

    Lilly, Innovent`s Mazdutide Nabs First-In-Class Nod in China

    FIERCE PHARMA

    UCB`s Fintepla shows potential to treat a 3rd epilepsy disorder

    FIERCE PHARMA

    US Senator Probes GSK`s Halt of Children`s Asthma Inhaler

    REUTERS

    Gilead Shares Rise After Top Court Ruling on Preventive Coverage

    REUTERS

    FDA Eliminates Risk Evaluation, Mitigation for Car-T Therapies

    REUTERS

    Pfizer`s Hemophilia Drug Hits Phase 3 Data Win

    FIERCE PHARMA

    Vor Bio`s surprise $4B revival Vor Biosplits investor reactions

    ENDPTS

    Orphalan partners with MAP International and Wilson Disease Assoc

    GLOBENEWSWIRE

    ProNephro AKI (NGAL) commercialization for US diagnostics

    GLOBENEWSWIRE

    Eton Pharmaceuticals Added to Russell 2000® and 3000® Indices

    GLOBENEWSWIRE

    Pharvaris to Present Deucrictibant Data at 2025 US HAEA Summit

    GLOBENEWSWIRE

    Tango Announces First Patient Dosed in Phase 1/2 Trial of TNG462

    GLOBENEWSWIRE

    BioCryst Sells European ORLADEYO Business to Neopharmed Gentili

    GLOBENEWSWIRE

    Foxo Technologies Sets New Preferred Stock for M&A Use

    GLOBENEWSWIRE

    HCW Biologics Updates on IND and Multi-Tumor TCE Program

    GLOBENEWSWIRE

    Allarity Therapeutics Doses Second Patient in Stenoparib Phase 2

    GLOBENEWSWIRE

    Ultragenyx Earns Breakthrough Status for GTX-102 in Angelman

    GLOBENEWSWIRE

    Lyra Therapeutics Announces $15M Offering Under Nasdaq Rules

    GLOBENEWSWIRE

    CorMedix Inc. Prices Public Offering of Common Stock

    GLOBENEWSWIRE

    Autonomix Gets U.S. Patent for Catheter Platform Tech

    GLOBENEWSWIRE

    Calidi Biotherapeutics Announces Shareholder Letter from CEO

    GLOBENEWSWIRE

    Jupiter Neurosciences Unveils Nugevia™ GLO for Skin Health

    GLOBENEWSWIRE

    Helius Medical Technologies Announces Reverse Stock Split

    GLOBENEWSWIRE

    Results of Annual General Meeting

    GLOBENEWSWIRE

    Experts Discuss Science Behind Choosing Best Maca Root Supplement

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.